BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22548315)

  • 21. In vivo evaluation of a novel albumin-binding prodrug of doxorubicin in an orthotopic mouse model of prostate cancer (LNCaP).
    Elsadek B; Graeser R; Esser N; Schäfer-Obodozie C; Tsurumi C; Abu Ajaj K; Warnecke A; Unger C; Saleem T; Kratz F
    Prostate Cancer Prostatic Dis; 2011 Mar; 14(1):14-21. PubMed ID: 21042336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
    McGowen R; Biliran H; Sager R; Sheng S
    Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.
    Colussi VC; Feyes DK; Mulvihill JW; Li YS; Kenney ME; Elmets CA; Oleinick NL; Mukhtar H
    Photochem Photobiol; 1999 Feb; 69(2):236-41. PubMed ID: 10048316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of albumin-binding doxorubicin prodrugs that are cleaved by prostate-specific antigen.
    Kratz F; Mansour A; Soltau J; Warnecke A; Fichtner I; Unger C; Drevs J
    Arch Pharm (Weinheim); 2005 Oct; 338(10):462-72. PubMed ID: 16211657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitors of urokinase reduce size of prostate cancer xenografts in severe combined immunodeficient mice.
    Jankun J; Keck RW; Skrzypczak-Jankun E; Swiercz R
    Cancer Res; 1997 Feb; 57(4):559-63. PubMed ID: 9044824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel polymeric prodrug with multivalent components for cancer therapy.
    Khandare JJ; Chandna P; Wang Y; Pozharov VP; Minko T
    J Pharmacol Exp Ther; 2006 Jun; 317(3):929-37. PubMed ID: 16469865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer.
    Solban N; Selbo PK; Sinha AK; Chang SK; Hasan T
    Cancer Res; 2006 Jun; 66(11):5633-40. PubMed ID: 16740700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylation status of uPA promoter as a molecular mechanism regulating prostate cancer invasion and growth in vitro and in vivo.
    Pakneshan P; Xing RH; Rabbani SA
    FASEB J; 2003 Jun; 17(9):1081-8. PubMed ID: 12773490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo prodrug therapy of prostate cancer using anti-gamma-Sm-scFv/hCPA fusion protein.
    Hao XK; Liu JY; Yue QH; Wu GJ; Bai YJ; Yin Y
    Prostate; 2006 Jun; 66(8):858-66. PubMed ID: 16491483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Photodynamic therapy with the phthalocyanine photosensitizer Pc 4 of SW480 human colon cancer xenografts in athymic mice.
    Whitacre CM; Feyes DK; Satoh T; Grossmann J; Mulvihill JW; Mukhtar H; Oleinick NL
    Clin Cancer Res; 2000 May; 6(5):2021-7. PubMed ID: 10815928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
    Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
    J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
    Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells.
    Tirand L; Frochot C; Vanderesse R; Thomas N; Trinquet E; Pinel S; Viriot ML; Guillemin F; Barberi-Heyob M
    J Control Release; 2006 Mar; 111(1-2):153-64. PubMed ID: 16423422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors.
    Gutova M; Najbauer J; Frank RT; Kendall SE; Gevorgyan A; Metz MZ; Guevorkian M; Edmiston M; Zhao D; Glackin CA; Kim SU; Aboody KS
    Stem Cells; 2008 Jun; 26(6):1406-13. PubMed ID: 18403751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of the expression of urokinase-type plasminogen activator from PC-3 human prostate cancer cells by thrombin.
    Yoshida E; Verrusio EN; Mihara H; Oh D; Kwaan HC
    Cancer Res; 1994 Jun; 54(12):3300-4. PubMed ID: 8205553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD10 is a key enzyme involved in the activation of tumor-activated peptide prodrug CPI-0004Na and novel analogues: implications for the design of novel peptide prodrugs for the therapy of CD10+ tumors.
    Pan C; Cardarelli PM; Nieder MH; Pickford LB; Gangwar S; King DJ; Yarranton GT; Buckman D; Roscoe W; Zhou F; Salles A; Chen TH; Horgan K; Wang YH; Nguyen T; Bebbington CR
    Cancer Res; 2003 Sep; 63(17):5526-31. PubMed ID: 14500390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pamidronate down-regulates urokinase-type plasminogen activator expression in PC-3 prostate cancer cells.
    Iguchi K; Tatsuda Y; Usui S; Hirano K
    Anticancer Res; 2007; 27(6B):3843-8. PubMed ID: 18225541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a novel prodrug of paclitaxel that is cleaved by prostate-specific antigen: an in vitro and in vivo evaluation study.
    Elsadek B; Graeser R; Esser N; Schäfer-Obodozie C; Abu Ajaj K; Unger C; Warnecke A; Saleem T; El-Melegy N; Madkor H; Kratz F
    Eur J Cancer; 2010 Dec; 46(18):3434-44. PubMed ID: 20933385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on preparation and photodynamic mechanism of chlorin P6-13,15-N-(cyclohexyl)cycloimide (Chlorin-H) and its antitumor effect for photodynamic therapy in vitro and in vivo.
    Yan YJ; Zheng MZ; Chen ZL; Yu XH; Yang XX; Ding ZL; Xu L
    Bioorg Med Chem; 2010 Sep; 18(17):6282-91. PubMed ID: 20691601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipophilic photosensitizer administration via the prostate arteries for photodynamic therapy of the canine prostate.
    Xiao Z; Owen RJ; Liu W; Tulip J; Brown K; Woo T; Moore RB
    Photodiagnosis Photodyn Ther; 2010 Jun; 7(2):106-14. PubMed ID: 20510305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.